Skip to main content

Patent Expiry

VSTM: AVMAPKI FAKZYNJA CO-PACK (COPACKAGED): recorded patent 11873296 expiry

December 29, 2042 · AVUTOMETINIB POTASSIUM; DEFACTINIB HYDROCHLORIDE. BioSniper AI can trace the company-impact path without requiring you to write the research question.

Event date
December 29, 2042
Company
Verastem, Inc. (VSTM)
Drug
AVUTOMETINIB POTASSIUM; DEFACTINIB HYDROCHLORIDE
BioSniper AIPage evidence connected

Prepared research question

What could this event change, and which evidence should be watched next?

Run cited research

Traceable citations · Unknowns marked

Patent Expiry

AVMAPKI FAKZYNJA CO-PACK (COPACKAGED): recorded patent 11873296 expiry

Orange Book application NDA219616, product 001, listed patent 11873296 expiry. Overall loss of exclusivity and current company rights: unknown.FDA source

Drug
AVUTOMETINIB POTASSIUM; DEFACTINIB HYDROCHLORIDE